In the last trading session, 3.88 million TNF Pharmaceuticals Inc (NASDAQ:TNFA) shares changed hands as the company’s beta touched 1.83. With the company’s per share price at $0.37 changed hands at $0.0 or -1.54% during last session, the market valuation stood at $1.00M. TNFA’s last price was a discount, traded about -845.95% off its 52-week high of $3.50. The share price had its 52-week low at $0.32, which suggests the last value was 13.51% up since then. When we look at TNF Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 2.54 million shares, with the 3-month average coming to 838.49K.
TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information
Instantly TNFA was in red as seen at the end of in last trading. With action 4.34%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -68.24%, with the 5-day performance at 4.34% in the green. However, in the 30-day time frame, TNF Pharmaceuticals Inc (NASDAQ:TNFA) is -1.30% down. Looking at the short shares, we see there were 0.78 million shares sold at short interest cover period of 1.18 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 67.29%.
TNFA Dividends
TNF Pharmaceuticals Inc is expected to release its next quarterly earnings report in May.
TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.59% of TNF Pharmaceuticals Inc shares while 15.10% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 15.19%.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 13.69 shares estimated at $4999.0 under it, the former controlled 0.50% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.41% of the shares, roughly 11.21 shares worth around $4094.0.
